Sang Hwan Seo

Title: Innovations of Sang Hwan Seo in Cervical Cancer Treatment

Introduction

Sang Hwan Seo is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment and prevention of cervical cancer. With a total of 4 patents to his name, his work focuses on innovative compositions that leverage the immune system to combat human papillomavirus (HPV).

Latest Patents

One of his latest patents is titled "Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer." This invention relates to a fusion protein that includes a fusion polypeptide of E6 and E7 of HPV, a signal peptide for secretion, and an immune-enhancing peptide. The patent also covers a pharmaceutical composition that utilizes this fusion protein for treating diseases caused by HPV. Another significant patent is "Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer." This composition includes a human papillomavirus plasmodium and an immunity enhancer, designed to induce an immune response against HPV types 16 and 18, which are known to trigger tumors.

Career Highlights

Sang Hwan Seo has worked with prominent organizations such as Genexine, Inc. and Postech Foundation. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of biotechnology and cancer treatment.

Collaborations

Some of his notable coworkers include Young Chul Sung and Hyun Tak Jin. Their collaborative efforts have contributed to the advancement of research in HPV-related therapies.

Conclusion

Sang Hwan Seo's innovative work in the field of cervical cancer treatment showcases the potential of combining immunology with biotechnology. His patents reflect a commitment to improving health outcomes for individuals affected by HPV.